INMED

Executives
Eric A. Adams,MIBS
Chief Executive Officer & President
Alexandra D.J. Mancini,MSc
Senior Vice President, Clinical & Regulatory Affairs
Eric C. Hsu, PhD
Senior Vice President, Pre-Clinical Research & Development
Shane Johnson
MD, SVP,General Manager of BayMedica
Michael Woudenberg, P.Eng.
Senior Vice President, Chemistry, Manufacturing & Controls
Philip Barr, PhD
VP, Discovery Research
Charles Marlowe, PhD
VP, Chemistry
Jim Kealey, PhD
VP, Synthetic Biology
Chris Meiering, PhD
VP, Commercial Operations
Jerry P. Griffin
VP, Sales and Marketing
Board
William Garner
MD, Chairman of the Board of Director
Janet Grove
QC, Director
Adam Cutler
Director
Andrew Hull
BA, Director
Bryan Baldasare
Director
Eric A. Adams, MIBS
Chief Executive Officer & President
Contact
Website
www.inmedpharma.com
Address
#310 – 815 West Hastings St. Vancouver, BC, Canada V6C 1B4
Twitter
twitter.com/inmedpharma?lang=en
Facebook
www.facebook.com/InMedPharma
Linkdin
www.linkedin.com/company/inmedpharma

About INMED

InMed is a leader in the manufacturing, development and commercialization of rare cannabinoids. Our manufacturing technologies produce several rare cannabinoids for pharmaceutical development and consumer products.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2023 Benzinga | All Rights Reserved